login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AMGEN INC (AMGN) Stock News
USA
- NASDAQ:AMGN -
US0311621009
-
Common Stock
291.76
USD
-1.13 (-0.39%)
Last: 10/24/2025, 8:08:51 PM
291.76
USD
0 (0%)
After Hours:
10/24/2025, 8:08:51 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AMGN Latest News, Press Relases and Analysis
All
Press Releases
16 hours ago - By: Benzinga
- Mentions:
BIIB
IFRX
Biogen's Immunology Pipeline Has Long-Term Potential: Analyst
18 hours ago - By: The Motley Fool
1 Top Dividend Growth Stock to Buy Right Now
a day ago - By: Zacks Investment Research
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
a day ago - By: Zacks Investment Research
- Mentions:
WFC
AMZN
AMX
MMC
...
Top Research Reports for Amazon.com, Wells Fargo & Amgen
2 days ago - By: Halper Sadeh LLC
Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights
8 days ago - By: Benzinga
Price Over Earnings Overview: Amgen
19 days ago - By: Stocktwits
- Mentions:
GDRX
Amgen To Sell Cholesterol Drug For Approximately 60% Discount
5 days ago - By: Zacks Investment Research
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
8 days ago - By: Amgen
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
23 days ago - By: Zacks Investment Research
- Mentions:
ADP
ABBV
Stock Market News for Oct 2, 2025
12 days ago - By: Zacks Investment Research
Why Amgen (AMGN) Could Beat Earnings Estimates Again
15 days ago - By: Zacks Investment Research
- Mentions:
JNJ
TEVA
KVUE
Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
18 days ago - By: The Motley Fool
- Mentions:
POR
CFR
CME
ASML
...
Martin Capital Buys Into Portland General Electric’s Defensive Power Play
19 days ago - By: Bloomberg
New Amgen Website Offers Repatha at 60% Off After Trump Pressure
19 days ago - By: Amgen
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
23 days ago - By: Zacks Investment Research
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
23 days ago - By: Investor's Business Daily
Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done
Please enable JavaScript to continue using this application.